Device Trial Radar · NCT05381961
Observational Study of BIS in Hemodialysis Patients
Last checked: Nov 20, 2026Latest source record: Sep 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
70
Planned (sponsor's estimate)
Start
Apr 4, 2022
Primary completion
Nov 8, 2022
Study completion Sep 2023
Sponsor
- Lead sponsor
- ImpediMed LimitedNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- California Institute of Renal Research; Frenova Renal Research
- First posted
- May 19, 2022
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This observational study will evaluate bioimpedance spectroscopy (BIS) measurements from patients undergoing hemodialysis.
Conditions
- Kidney Failure, Chronic
- Renal Failure Chronic
- Hemodialysis
Interventions
Bioimpedance spectroscopy (BIS) measurement, SOZO deviceDevice
All patients enrolled in this study will undergo BIS measurement before and after 12 hemodialysis sessions (pre-dialysis and post-dialysis BIS measurements for each session). Measurements are not provided to treating physicians and are not used to guide clinical decisions; i.e., BIS measurements are collected for observational purposes only.
Primary outcomes
What the sponsor says the trial is designed to measure.
- BIS correlation with amount of fluid dialyzedTime frame: 12 hemodialysis sessions (over 4 to 6 weeks)
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Balboa Research - Kearny Mesa
San Diego, California
Balboa Research - Rancho Bernardo
San Diego, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.